Elevated chromogranin A (CgA) serum levels in the patients with advanced pancreatic cancer

Michele Malaguarnera, Erika Cristaldi, Lisa Cammalleri, Valentina Colonna, Helga Lipari, Alessandra Capici, Andrea Cavallaro, Massimiliano Beretta, Innocenza Alessandria, Salvatore Luca, Massimo Motta

Research output: Contribution to journalArticle

Abstract

The neuroendocrine differentiation in PC could potentially represent a new finding with diagnostic, prognostic and therapeutic implications. This study aimed at evaluating the clinical usefulness of CgA as a neuroendocrine (NE) serum-marker. We investigated the role of the serum concentration of CgA in a study group of patients with PC. CgA was significantly higher in the patients affected by PC as compared with the group of healthy subjects (HS) and those with chronic pancreatitis (CHP) (p <0.001). Also the HS group differed significantly from the CHP control group in the serum CgA levels (p <0.001). The serum carbohydrate antigen (CA19-9) level displayed a significant difference (p <0.001) between the PC and the HS group. The PC and CHP groups, as well as the HS and CHP groups showed also significant differences in the CA19-9 levels (p <0.001). One can conclude that the patients with higher CgA levels had poorer prognosis and survival, as compared to those with lower CgA levels. These results support the notion that the determination of serum CgA level before treatment may be a potential prognostic factor for PC.

Original languageEnglish
Pages (from-to)213-217
Number of pages5
JournalArchives of Gerontology and Geriatrics
Volume48
Issue number2
DOIs
Publication statusPublished - Mar 2009

Keywords

  • Carbohydrate antigen (CA19-9)
  • Chromogranin A
  • Neuroendocrine components
  • Pancreatic cancer

ASJC Scopus subject areas

  • Ageing
  • Geriatrics and Gerontology
  • Health(social science)
  • Gerontology

Fingerprint Dive into the research topics of 'Elevated chromogranin A (CgA) serum levels in the patients with advanced pancreatic cancer'. Together they form a unique fingerprint.

  • Cite this

    Malaguarnera, M., Cristaldi, E., Cammalleri, L., Colonna, V., Lipari, H., Capici, A., Cavallaro, A., Beretta, M., Alessandria, I., Luca, S., & Motta, M. (2009). Elevated chromogranin A (CgA) serum levels in the patients with advanced pancreatic cancer. Archives of Gerontology and Geriatrics, 48(2), 213-217. https://doi.org/10.1016/j.archger.2008.01.014